LOS ANGELES--(BUSINESS WIRE)--Sensydia, a medical technology company pioneering non-invasive cardiac assessment, today announced that the first patient has been enrolled in its multi-center pivotal ...

Mayo Clinic research identified a powerful new way to improve the prediction of a patient's long-term cardiovascular disease ...

LOS ANGELES--(BUSINESS WIRE)--Non-invasive cardiac assessment company Sensydia today announced it has raised approximately $8M in new funding from an expanded syndicate of investors. Proceeds of the ...

The entire process of atherogenesis, including initiation, growth, and complication, can be seen as an inflammatory response to injury. Factors, such as cigarette smoking, hypertension, atherogenic ...

A new system that uses artificial intelligence (AI) to assess cardiovascular risk based on images of the eye captured during ...

SAN FRANCISCO, March 16, 2026 /PRNewswire/ -- Allelica, a leader in genomic risk assessment for common diseases, announced today that polygenic risk scores (PRS) have been recognized as a ...

Chronic kidney disease (CKD) is a strong cardiovascular risk factor and is often accompanied by hypertension and diabetes. Despite the disease's prevalence - 10 percent of individuals across the globe ...

Patient being positioned for MR study of the head and abdomen. — Image by Ptrump16. CC BY-SA 4.0 Patient being positioned for MR study of the head and abdomen. — Image by Ptrump16. CC BY-SA 4.0 The ...

SALT LAKE CITY, Feb. 02, 2021 (GLOBE NEWSWIRE) -- To help more patients with rheumatoid arthritis (RA), Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today ...